Swiss All Share Index
15.848,14
PKT
+74,77
PKT
+0,47
%
Werbung
Analysen zu Swiss All Share Index-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 02.02.05 | Swatch (I) Buy | Sarasin Research | |
| 02.02.05 | Roche Halten | Helaba Trust | |
| 03.02.05 | Novartis Übergewichten | Reuschel & Co | |
| 03.02.05 | Roche Buy | Sarasin Research | |
| 01.02.05 | UBS Neutral | Merrill Lynch | |
| 01.02.05 | Novartis Kaufen | SYZ & CO | |
| 01.02.05 | Roche Halten | Helaba Trust | |
| 01.02.05 | UBS Buy | Sarasin Research | |
| 01.02.05 | Zurich Insurance Buy | Sarasin Research | |
| 01.02.05 | UBS Buy | Merrill Lynch | |
| 31.01.05 | Novartis Outperform | Credit Suisse First Boston | |
| 31.01.05 | Roche Buy | Sarasin Research | |
| 02.02.05 | UBS Outperform | Credit Suisse First Boston | |
| 01.02.05 | Logitech Kauf | SYZ & CO | |
| 01.02.05 | Roche Neutral | Credit Suisse First Boston | |
| 31.01.05 | Lonza Reduce | Sarasin Research | |
| 01.02.05 | ARYZTA Buy | Helvea | |
| 31.01.05 | Nestlé Neutral | Sarasin Research | |
| 31.01.05 | Vetropack A Market Perform | Vontobel | |
| 01.02.05 | Schindler Neutral | Helvea | |
| 28.01.05 | Holcim Verkaufen | Helaba Trust | |
| 31.01.05 | Novartis Buy | Helvea | |
| 31.01.05 | Swatch (I) Buy | Sarasin Research | |
| 27.01.05 | Lonza Buy | Helvea | |
| 27.01.05 | Holcim Neutral | Helvea | |
| 03.02.05 | Novartis Outperformer | Sparkasse KölnBonn | |
| 28.01.05 | Swatch (I) Neutral | JP Morgan | |
| 27.01.05 | Holcim Halten | Helaba Trust | |
| 27.01.05 | Adecco SA Accumulate | Helvea | |
| 26.01.05 | Novartis Market Perform | William Blair | |
| 26.01.05 | Lonza Reduce | Sarasin Research | |
| 26.01.05 | UBS Buy | Sarasin Research | |
| 26.01.05 | Lindt In-Line | Goldman Sachs | |
| 26.01.05 | ARYZTA Neutral | Sarasin Research | |
| 26.01.05 | Lindt Neutral | Sarasin Research | |
| 25.01.05 | Holcim Accumulate | Helvea | |
| 25.01.05 | Adecco SA Accumulate | Helvea | |
| 25.01.05 | Novartis Halten | LB Baden-Württemberg | |
| 25.01.05 | Lindt Neutral | Helvea | |
| 25.01.05 | Novartis Buy | Helvea |